ARTICLES BY THIS AUTHOR
- 5/31/2021
Biologic tezepelumab shows positive results in severe, uncontrolled asthma
Tezepelumab is associated with reduced exacerbations, hospitalizations and ER visits in people with severe, uncontrolled asthma. It may also challenge the current step of biomarker assessment before initiating treatment with a biologic. - 5/31/2021
Many private-sector Mexican healthcare workers haven't yet received a first dose
Wait your turn - 5/31/2021
What is the optimal dose of ASA for risk reduction in atherosclerotic CV disease?
U.S. study compares 81 mg vs 325 mg ASA to lower cardiovascular risk and mortality in patients with established atherosclerotic cardiovascular disease. - 5/31/2021
Spotlight 4: Pharmacist’s blessings